With regard to a new GLP-1 RA, a study was conducted in db/db mice, an experimental model of T2D, to assess and compare the therapeutic efficacy of liraglutide, tirzepatide, and retatrutide in treating DKD [46]. This evidence concerns the gene GLP1R and diabetic kidney disease.